in triglycerides and alanine transaminase were observed in the group with a vitamin D insufficiency (p = 0.002 and 0.011, respectively). After adjusting for physical activity and dietary habit scores, vitamin D insufficiency remained significantly associated with metabolic syndrome and hypertension. Discussion: Vitamin D insufficiency was associated with metabolic syndrome and was particularly associated with high blood pressure, although the nature, direction and implications of this association are unclear. 
T161. HEARING VOICES AMONG INDIGENOUS
Background: Studies of the health of indigenous and tribal people can shed light on health inequalities with implications for global mental health. Almost no previous studies of mental health among the Maasai in Kenya or Tanzania or even pastoralist groups in general are available, with the exception of one mentioning the stress of rural-to-urban migration. While engaged in ethnographic research in 2013, Myers interviewed 13 Maasai women in northern Tanzania about their everyday lives. Interested in the phenomenology of voice-hearing, she also asked them if they heard voices. Eleven of the women (85%) reported regularly hearing voices that they found to be distressing. Myers returned in 2015 to collect data from a larger sample, which has resulted in this report. Methods: For this study, we used a convenience sample (n=73) of females taken from a broader study whose eligibility criteria included being a Maasai person living in the Arusha Region of Tanzania and over the age of 18. We excluded people who reported being psychiatric patients or family members of patients being seen by the local mental health coordinator to create a nonclinical community sample. This project conducted an initial survey to: 1) estimate the community prevalence of voice-hearing, or auditory verbal hallucinations (AVHs) in this specific population; and, 2) examine any demographic correlates and two specific hypothesized correlates based on previous literature about voice-hearing (e.g., psychological stress and potentially traumatic events).
Results:
The prevalence of AVHs in this community sample was quite high compared to other studies in sub-Saharan Africa, at 34.3%. There were no differences between participants who did and did not experience AVHs in terms of demographics, but those experiencing AVHs had a statistically significantly higher level of psychological distress (30.1, SD=6.0, compared to 25.1, SD=6.0), with a Cohen's d effect size of .87. Even though a numerical difference was observed in terms of potentially traumatic events (4.6, SD=2.1, compared to 3.8, SD=2.3), this difference was not statistically significant (d=.38). Discussion: Hearing distressing voices may be an indicator of mental ill health that is easily recognizable to community health workers and brings much-needed attention to communities in need. Maasai women face tremendous social adversity in this time of rapid social, economic, and climate change in the region. Evidence for a link between stressful life events, social disadvantage, and the development of psychotic symptoms is strong in Europe, but not as well-developed in this region. The high level of psychosocial stress and AVHs in our sample may also be indicative of extreme social adversity. Maasai women have been historically disenfranchised since the advent of colonial and postcolonial policies favoring men. Women in this region also experiences extreme states of deprivation, including a 21.5 year gap in life expectancy at birth compared to the local population (for all Maasai), 81% severe food insecurity, and a rate of 59% for the stunted growth of children (as compared to their neighbors, the Meru, with 21% of children with stunted growth). Due to local livelihood insecurity, the age of first marriage has been decreasing, resulting in increased pressure on women. This analysis contextualizes these findings and calls for further research on the epidemiology of voice-hearing in this region, as well as further work on the phenomenology of these AVHs so that we can best understand how to address them and improve mental health outcomes for this marginalized group. Background: Recent studies have shown aberrant gyrification, i.e. folding of the cortical surface, as a marker of disturbed neocortical development in schizophrenia. Unlike more commonly used markers like voxel-based morphometry, these parameters might be more sensitive to early neurodevelopmental pathologies. It is unclear, however, whether such structural changes might be evident across the schizophrenia spectrum, involving at-risk subjects as well as even healthy subjects with subclinical or attenuated psychotic(-like) symptoms Methods: We analysed high-resolution MRI scans (3 Tesla, T1-weighted MPRAGE, 1x1x1mm resolution) from n=177 healthy subjects with no current or previous psychiatric condition recruited from the local community. Subjects completed the SCL90R, a general symptom checklist (i.e. self-rating of symptoms), which includes subscales for psychoticism (with subclinical psychotic/-like symptoms) and paranoid ideation. We used the CAT12 toolbox to analyse both gyrification using the absolute mean curvature approach (Luders et al., NeuroImage 2006, as well as cortical thickness and voxel-based morphometry (VBM).
T162. LEFT PREFRONTAL GYRIFICATION
Results: Correcting for effects of age and gender, we found a significant negative correlation between SCL90R psychoticism scores and gyrification in a left prefrontal / frontopolar cluster, but no similar finding for wither cortical thickness analysis nor analyses of the paranoid ideation subscale. Discussion: Our results suggest that prefrontal gyrification might be a marker for psychotic phenotypes spanning a spectrum from subclinical symptom expression to frank psychosis. This association seems linked to gyrification (rather than other markers of brain structure), which would suggest a relative specificity. Hence, this would be consistent with the assumption that gyrification is related to early neurodevelopmental effects, which lead to liabity to experiencing psychotic symptoms later in life, and might thus serve as an imaging phenotype for early risk detection and intervention in high-risk groups. Background: Structural neuroimaging studies report disrupted morphological relationship in the grey matter volume (structural covariance) in patients with schizophrenia, indicating an impairment in functional and/ or developmental plasticity. To our knowledge, no studies have examined the alterations in structural covariance across the entire brain in drug-naïve first episode psychosis. TOPSY (Tracking Outcomes of Psychosis) is one of the first studies intending to track the neurobiological trajectory using ultra-high field (7T) imaging starting from a drug-naïve first episode state. Here, we report the initial findings from the structural covariance of grey matter volume. To our knowledge, this is the first structural covariance analysis being reported using a 7T anatomical MRI acquisition. Methods: We used ultra-high field (7 Tesla) MRI in 28 patients with FEP (satisfying criterion A of DSM-5 schizophrenia) and 18 controls, to estimate grey matter volume in a voxelwise manner. FEP and controls were matched for age, sex and parental socioeconomic status. Patients were recruited at an early intervention unit (PEPP, London Ontario) and had active psychotic symptoms at the time of scanning. Morphometric analysis was done using SPM12, after DARTEL based registration and segmentation but without spatial smoothing on 160 brain regions (6mm spheres) obtained using Dosenbach's atlas. Correlation matrix for each group was constructed from 160*160 pearson correlation coefficients, followed by estimation of a bias matrix for each subject using jack-knife bias estimation. Bias values for each pair of nodes in an individual subject quantified the contribution of that subject to the overall within-group covariance. Higher positive values meant greater covariance between the two given nodes in that subject, relative to the rest of the group. These bias matrices can be considered equivalent to demeaned and normalised matrices of structural covariance. Structural covariance across all possible regional pairwise connections was tested using 2-tailed voxelwise T-test with FDR correction (p=0.05, 5% rate for false positives).
Results: Patients had a significant reduction in structural covariance affecting between right posterior insula and right precentral gyrus (within sensorimotor network, t=3.86, Hedge's g = 1.15); between right posterior insula and left ventral prefrontal cortex (between sensorimotor and salience network, t=3.71, Hedge's g = 1.10); and between right anterior cingulate cortex and right dorsal prefrontal cortex (between sensorimotor and default-mode network, t=3.10, Hedge's g = 0.92). There were no pairwise connections with increased structural covariance among FEP subjects compared to healthy controls. Discussion: Our findings suggest that (1) structural covariance is disrupted even by the time of first-episode of psychosis; thus, the disruptions in morphological relationships reported in schizophrenia are not explicable by antipsychotic usage or illness duration (2) sensorimotor network regions show a predominant disruption in structural covariance, affecting morphological relationships with both salience and default mode regions. The functional and developmental plasticity of sensorimotor networks may be crucial for the early trajectory of psychosis. Background: Structural neuroimaging studies report distributed grey matter volume (GMV) deficits in drug-naïve first episode psychosis (FEP), though their relevance to symptom burden and cognitive deficits is currently unclear. When compared to studies in medicated patients and/or patients with established later-stage of psychosis, the GMV deficits reported have been limited in both spatial distribution and effect size, indicating the possibility of stage-specific progression during the clinical course of psychosis. TOPSY (Tracking Outcomes of Psychosis) is one of the first studies intending to track the neurobiological trajectory using ultra-high field (7T) imaging starting from a drug-naïve first episode state. Here, we report the initial findings from the voxelbased morphometry (VBM) of GMV. To our knowledge, this is the first VBM report from drug-naïve FEP subjects obtained using a 7T MRI acquisition. Methods: We used ultra-high field (7 Tesla) MRI in 28 patients with FEP (satisfying criterion A of DSM-5 schizophrenia) and 18 controls, to evaluate differences in the grey matter. Volume in a voxelwise manner. FEP and controls were matched for age, sex and parental socioeconomic status. Patients were recruited at an early intervention unit (PEPP, London Ontario) and had active psychotic symptoms at the time of scanning. We also obtained abbreviated PANSS (8 items) scores to index the severity of psychosis. Analysis was done using SPM12, after DARTEL based registration and segmentation but without spatial smoothing. 2-tailed voxelwise T-test with FDR correction (p=0.05, 5% rate for false positives) was used. We used multiple regression analysis to predict the scores from processing speed measure (modified Symbol Substitution Test) and the severity of Delusions and Unusual Thought Content (P1 and G9), the 2 symptoms for which most subjects sought treatment in the first place.
T165. ULTRA-HIGH FIELD MORPHOMETRY IN DRUG-NAÏVE FIRST EPISODE PSYCHOSIS

